Middle East’s First BlueSeal XE MRI System Installed in Lebanon
The American University of Beirut Medical Center has installed the Middle East's…
M42’s IROS Launches UAE’s First Genomics-Driven Clinical Trial to Prevent Alzheimer’s Disease
M42's IROS has launched the UAE's first genomics-driven clinical trial to prevent…
Lilly, Abu Dhabi Department of Health partner to advance AI-Powered Obesity and Alzheimer’s Care
Lilly and the Department of Health – Abu Dhabi have partnered to…
Sysmex Launches an Assay Kit for Identifying p-Tau217 in the Blood, a Biomarker Related to Alzheimer’s Disease
Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui) announced that it has…
Rehabilitation must be at the heart of dementia care across Middle East and Africa, urges new World Alzheimer Report
Dementia cases are rising faster across the Middle East and Africa than…
Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that…
FDA Approves Updated Label for GE Healthcare’s Vizamyl to Enhance Alzheimer’s Diagnosis and Therapy Monitoring
GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has…
